Ticker

Analyst Price Targets — FMS

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
January 5, 2026 12:19 pmTruist Financial$28.00$23.51TheFly Fresenius Medical price target raised to $28 from $26 at Truist
May 15, 2024 9:07 amDavid MacDonaldTruist Financial$24.00$22.48TheFly Fresenius Medical price target raised to $24 from $21 at Truist
January 2, 2023 7:30 pmJames Vane-TempestJefferies$11.70$16.34TheFly Fresenius Medical downgraded to Underperform from Buy at Jefferies
June 22, 2022 7:28 amTruist Financial$27.00$23.64Benzinga Truist Securities Maintains Hold on Fresenius Medical Care, Lowers Price Target to $27

Latest News for FMS

Reviewing Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Bluejay Diagnostics (NASDAQ:BJDX)

Fresenius Medical Care AG and Co. KGaA (NYSE: FMS - Get Free Report) and Bluejay Diagnostics (NASDAQ: BJDX - Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, earnings and dividends. Analyst Recommendations This

Defense World • Apr 13, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for FMS.

House Trades Disclosures

NameTransaction DateTypeAssetAmountLink

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top